CIK: 1529196 - Address: C/O Revance Therapeutics, Inc., 1222 Demonbreun Street, 20Th Floor, Nashville, TN 37203
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/8/24 16:33
3/6/24
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsFoley Mark JTNDOCEOP2096.9803031,126D
2/26/24 19:01
2/23/24
GKOSGlaukos CorpDEHealthMdEqSurgical & Medical InstrumentFoley Mark JCADM.d737.280104333D
2/26/24 19:01
2/23/24
GKOSGlaukos CorpDEHealthMdEqSurgical & Medical InstrumentFoley Mark JCADS.d-42392.870-5-1233D
8/4/23 17:07
8/3/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsFoley Mark JTNDOCEOS-59322.570-26-3951D
7/5/23 21:11
7/3/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsFoley Mark JTNDOCEOS-65524.940-26-3978D
6/13/23 20:09
6/9/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsFoley Mark JTNDOCEOS-96130.720-31-31,003D
5/16/23 20:29
5/15/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsFoley Mark JTNDOCEOS-2,43434.550-70-61,034D
3/9/23 21:45
3/9/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsFoley Mark JTNDOCEOS-2,22331.590-70-7934D
11/29/21 21:24
11/29/21
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsFoley Mark JTNDOCEOP51612.900405880I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact